Lobbying Filing Details

Total Spending

$60,000

Activities

1

Lobbyists

6

Gov't Entities

2

Filing Information
Filing UUID:
c5305ed6-53d3-4bbf-bdaa-3f5dbfcbb04e
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 7:29 PM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
TODD STRATEGY GROUP

​Government Affairs Consulting Firm.

Washington, District of Columbia
Client
ALNYLAM PHARMACEUTICALS, INC.

Biopharmaceutical company

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Medicare/Medicaid

Medicare and Medicaid Issues. H.R.1672: Maintaining Investments in New Innovation Act. H.R.946: ORPHAN Cures Act.

Lobbyists (6)
  • DANIEL M TODD
  • PAUL EDATTEL
  • TED LEHMAN
  • KATHERINE FLEMING COTTON
  • ERIC BERGREN
  • MR. NICOLAS MAGALLANES
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 18, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.